Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2731 AL 2745

Impact of frailty and sex-related differences on postural control and gait in older adults with Parkinson's Disease

Dallaire M, Houde-Thibeault A, Bouchard-Tremblay J, Wotto EA, Côté S, Santos Oliveira C, Ngomo S, da Silva RA.

Exp Gerontol. 2024 Feb;186:112360. doi: 10.1016/j.exger.2024.112360. Epub 2024 Jan 13.

Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research

James D, Smith J, Lane E, Thomas R, Brown S, Seage H.

Explor Res Clin Soc Pharm. 2024 May 7;14:100450. doi: 10.1016/j.rcsop.2024.100450. eCollection 2024 Jun.

A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson's Disease

Das S, Ramteke H.

Cureus. 2024 Feb 16;16(2):e54337. doi: 10.7759/cureus.54337. eCollection 2024 Feb.

GBA1-Associated Parkinson's Disease Is a Distinct Entity

Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G, Cohen ME, Revel-Vilk S, Goker-Alpan O, Becker-Cohen M, Hassin-Baer S, Svenningsson P, Rolfs A, Zimran A.

Int J Mol Sci. 2024 Jun 28;25(13):7102. doi: 10.3390/ijms25137102.

Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action

N P D, Kondengadan MS, Sweilam SH, Rahman MH, Muhasina KM, Ghosh P, Bhargavi D, Palati DJ, Maiz F, Duraiswamy B.

Biotechnol Genet Eng Rev. 2024 Dec;40(4):3346-3378. doi: 10.1080/02648725.2022.2122296. Epub 2022 Oct 8.

Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target

Bhushan B, Singh NK.

CNS Neurol Disord Drug Targets. 2024;23(8):1015-1029. doi: 10.2174/0118715273270473231002104610.

Exercise and gait/movement analyses in treatment and diagnosis of Parkinson's Disease

Burtscher J, Moraud EM, Malatesta D, Millet GP, Bally JF, Patoz A.

Ageing Res Rev. 2024 Jan;93:102147. doi: 10.1016/j.arr.2023.102147. Epub 2023 Nov 28.

Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability

Wei BR, Zhao YJ, Cheng YF, Huang C, Zhang F.

Immun Ageing. 2024 Jan 2;21(1):1. doi: 10.1186/s12979-023-00404-1.

The Neuroprotective Effects of Electroacupuncture on Parkinson's Disease and the Underlying Molecular Mechanisms

Han Q, Chen P, Chen X, Wang L, Huang R, Li W, Liu G.

J Integr Neurosci. 2024 Jan 16;23(1):11. doi: 10.31083/j.jin2301011.

Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges

Watanabe H, Dijkstra JM, Nagatsu T.

Int J Mol Sci. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009.

Beta-Gamma Phase-Amplitude Coupling as a Non-Invasive Biomarker for Parkinson's Disease: Insights from Electroencephalography Studies

Hodnik T, Roytman S, Bohnen NI, Marusic U.

Life (Basel). 2024 Mar 15;14(3):391. doi: 10.3390/life14030391.

Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics

Demailly A, Moreau C, Devos D.

J Parkinsons Dis. 2024;14(5):925-939. doi: 10.3233/JPD-230372.

Exploring circular RNAs as biomarkers for Parkinson's disease and their expression changes after aerobic exercise rehabilitation

de Abreu FMC, de Oliveira DA, de Araujo Romero Ferrari SS, E Silva KHCV, Titze-de-Almeida R, Titze-de-Almeida SS.

Funct Integr Genomics. 2024 Jul 29;24(4):130. doi: 10.1007/s10142-024-01409-9.

From prodromal stages to clinical trials: The promise of digital speech biomarkers in Parkinson's disease

Rusz J, Krack P, Tripoliti E.

Neurosci Biobehav Rev. 2024 Dec;167:105922. doi: 10.1016/j.neubiorev.2024.105922. Epub 2024 Oct 18.

Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson's and other related neurodegenerative diseases

Riaz Z, Richardson GS, Jin H, Zenitsky G, Anantharam V, Kanthasamy A, Kanthasamy AG.

Mol Neurodegener. 2024 Nov 23;19(1):87. doi: 10.1186/s13024-024-00774-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias